SELLAS Life Sciences Group, Inc. (SLS) Tops Q1 EPS by 2c

SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) reported Q1 EPS of ($0.05), $0.02 better than the analyst estimate of ($0.07).

For earnings history and earnings-related data on SELLAS Life Sciences Group, Inc. (SLS) click here.

You May Also Be Interested In

• Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
• Innovex closes $95M acquisition of TCO Group AS
• Sec Probes Alleged Insider Options Trades That Hit Susquehanna - Bloomberg